Live Breaking News & Updates on Science And Technology In The Peoples Republic Of China

Stay updated with breaking news from Science and technology in the peoples republic of china. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

US Capital Global Securities Closes $10MM Financing for Cardax, Inc.

Global private financial group supports the growth of development-stage biopharmaceutical company combatting cardiovascular disease, arthritis, and ageing. ....

United States , San Francisco , Charles Towle , Us Capital Global Securities , Cardax Inc , Global Securities , Asset Management , Cardiovascular Disease , Corporate Finance , Financial Industry Regulatory Authority , Financial Services , It Security , Life Sciences , Pharmaceutical Industry , Pharmaceuticals Policy , United States Securities Law , Wealth Management , Otc Markets Group , Pharmaceutical Industry In China , Pharmacy In China , Science And Technology In The Peoples Republic Of China ,

Government Issues Operational Guidelines For Production Linked Incentive Scheme Of Pharmaceuticals

Government has issued Operational guidelines for Production Linked Incentive Scheme of Pharmaceuticals. The Department of Pharmaceuticals notified the Production Linked Incentive (PLI) Scheme for Pharmaceuticals on 3rd March, 2021. The approved outlay of the scheme is Rs 15000 crore. The scheme envisages to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains. Based on a series of consultations with pharmaceutical industry and stakeholders in the Government, the operational guidelines for the scheme have been prepared and issued on 1st June. The scheme is now open to applications from the industry. ....

Department Of Pharmaceuticals , Production Linked Incentive Scheme Of Pharmaceuticals , Production Linked Incentive Scheme , Production Linked Incentive , Global Manufacturing Revenue , Capital Market , Pharmaceuticals Policy , Pharmaceutical Industry In China , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Ministry Of Chemicals And Fertilizers , Raft Production Linked Incentive Pli , Active Pharmaceutical , துறை ஆஃப் மருந்துகள் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை திட்டம் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , உலகளாவிய உற்பத்தி வருவாய் , மூலதனம் சந்தை , மருந்துகள் பாலிஸீ ,

India adds 12.1 GW power generation capacity in FY21: Report

India added 12.1 gigawatt (GW) power generation capacity in 2020-21, of which 7.7 GW was from renewable energy sources, according to a report.
India s total power generation also increased by 1.3 per cent in FY21 despite pandemic restrictions, driven by a post-lockdown surge in electricity demand. The share of RE in the energy mix was 10.1 per cent, up from 9.4 per cent in FY20, the CEEW Centre for Energy Finance (CEEW-CEF) Market Handbook said.
The CEEW-CEF Market Handbook provides independent market intelligence to investors, executives and policymakers every quarter on the energy sector.
Renewable energy (RE) dominated power generation capacity addition in FY21, accounting for 7.7 GW (64 per cent) of the 12.1 GW added, the report said. ....

Nikhil Sharma , Gagan Sidhu , Water Co , Centre For Energy Finance , Council On Energy , Aljomaih Energy , Energy Finance , Market Handbook , Coal India , Science And Technology In The Peoples Republic Of China , Technological Change , Ndustry In China , Bright Green Environmentalism , Renewable Energy , Renewable Energy Technology , Lectricity Sector In China , Solar Power By Country , Coal Nec , நிகில் ஷர்மா , ககன் ஸிட்ஹு , தண்ணீர் இணை , மையம் க்கு ஆற்றல் நிதி , சபை ஆன் ஆற்றல் , ஆற்றல் நிதி , சந்தை கையேடு , நிலக்கரி இந்தியா ,

Aarti Drugs' unit gets approval under pharma PLI scheme

Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs 6,940 crore.
The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. The tenure of the scheme is from FY21 to FY30. ....

Adhish Patil , Government Of India Department Pharmaceuticals , Ministry Of Chemicals , Aarti Speciality Chemicals , Aarti Drugs , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Active Pharmaceutical Ingredients , Speciality Chemicals , Target Segment , Key Chemical Synthesis Based , Drug Intermediates , Chief Financial Officer , Pharma Intermediates , Capital Market , Pharmaceutical Industry In China , Pharmaceuticals Policy , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Chemical Substance , Physical Sciences , Natural Sciences , Companies Based In , அரசு ஆஃப் இந்தியா துறை மருந்துகள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் ,

Pharma stocks rally after cabinet approves PLI scheme

Shares of eight pharmaceutical companies rose by 0.5% to 3.4% after the cabinet approved Production Linked Incentive (PLI) scheme for pharmaceuticals segment.Hikal (up 3.46%), Neuland Laboratories (up 3.08%), IPCA Laboratories (up 2.85%), Alkem Laboratories (up 1.43%), Torrent Pharmaceutical (up 1.09%), Biocon (up 0.6%), Cadila Healthcare (up 0.58%) and Aurobindo Pharma (up 0.52%) were top gainers in pharmaceutical space.
The Union Cabinet on Wednesday approved Production Linked Incentive (PLI) scheme for pharmaceuticals over a period of Financial Year 2020-21 to 2028-29.
The scheme will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers. The scheme is also expected to bring in investment of Rs 15,000 crore in the pharmaceutical sector. ....

Aurobindo Pharma , Union Cabinet On , Production Linked Incentive , Neuland Laboratories , Alkem Laboratories , Torrent Pharmaceutical , Cadila Healthcare , Union Cabinet , Financial Year , Diagnostic Devices , Capital Market , Health Sciences , Health Care , Pharmaceuticals Policy , Pharmaceutical Industry In China , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Pharmaceutical Industry , Pharmaceutical Space , அரவிந்தோ பார்மா , தொழிற்சங்கம் மந்திரி சபை ஆன் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , அல்கெம் ஆய்வகங்கள் , நீரோடை மருந்து , காடிலா சுகாதாரம் , தொழிற்சங்கம் மந்திரி சபை ,